The startup develops AI-driven medical imaging technologies that specialize in the segmentation of MRI and CT images for diagnosing degenerative brain diseases, including dementia and Parkinson's disease. Their platform also automates the analysis of breast, thyroid, and liver cancer images, enhancing diagnostic accuracy and efficiency for healthcare practitioners.
Funding
$4.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Diagnosing degenerative brain diseases and cancers through medical imaging is often a time-consuming and complex process, requiring manual segmentation and analysis of MRI and CT scans. This can lead to variability in diagnoses and delays in treatment.
Solution
The company offers AI-powered medical imaging solutions that automate the segmentation and analysis of MRI and CT images. Their platform specializes in detecting and diagnosing degenerative brain diseases like dementia and Parkinson's disease through NeurOMX. Additionally, their MediOMX solution automates the analysis of breast, thyroid, and liver cancer images, enhancing diagnostic accuracy and efficiency. The platform aims to streamline clinical workflows, reduce diagnostic errors, and accelerate treatment planning.
Target Audience
The primary target audience includes radiologists, oncologists, neurologists, and other healthcare professionals involved in the diagnosis and treatment of degenerative brain diseases and cancers.
Features
- AI-driven segmentation of MRI and CT images for brain, breast, thyroid, and liver analysis
- Automated detection and diagnosis of degenerative brain diseases (NeurOMX)
- Automated analysis of breast, thyroid, and liver cancer images (MediOMX)
- Cloud-based platform for secure data storage and accessibility
- User-friendly interface for easy navigation and interpretation of results
- Integration with existing hospital systems and workflows
- AI-based SaMD (Software as a Medical Device) for precise analysis of degenerative diseases